Wortmann G, Sweeney C, Houng H S, Aronson N, Stiteler J, Jackson J, Ockenhouse C
Walter Reed Army Medical Center, Washington, District of Columbia, USA.
Am J Trop Med Hyg. 2001 Nov;65(5):583-7. doi: 10.4269/ajtmh.2001.65.583.
A fluorescent DNA probe (LEIS.P1) specific for a conserved region of the small-subunit ribosomal RNA gene of Leishmania and a pair of flanking primers (LEIS.U1 and LEIS.L1) were designed for use in a fluorogenic polymerase chain reaction. Optimal assay conditions with zero background were established to detect low levels of Leishmania from clinical samples. By use of this assay, we amplified DNA from 27 strains of cultured Leishmania (both Old and New World strains) and selectively amplified Leishmania DNA from 12 paraffin-embedded human biopsy samples and 3 fresh human skin biopsy specimens. For the fresh human tissue biopsies, the turnaround time from biopsy to test result was < 24 hr. No amplification was detected in negative control samples (including the kinetoplastid protozoa Trypanosoma rangelli and Crithidia fasiculata). This assay provides a specific and rapid diagnostic modality to detect infection with Leishmania.
设计了一种针对利什曼原虫小亚基核糖体RNA基因保守区域的荧光DNA探针(LEIS.P1)和一对侧翼引物(LEIS.U1和LEIS.L1),用于荧光聚合酶链反应。建立了零背景的最佳检测条件,以检测临床样本中低水平的利什曼原虫。通过使用该检测方法,我们从27株培养的利什曼原虫(包括旧世界和新世界菌株)中扩增了DNA,并从12份石蜡包埋的人体活检样本和3份新鲜人体皮肤活检标本中选择性地扩增了利什曼原虫DNA。对于新鲜人体组织活检,从活检到检测结果的周转时间<24小时。在阴性对照样本(包括动基体原生动物朗氏锥虫和束状克氏锥虫)中未检测到扩增。该检测方法为检测利什曼原虫感染提供了一种特异且快速的诊断方式。